Iranian Journal of Pediatrics

Published by: Kowsar

Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children

Semiha Bahceci Erdem 1 , Hikmet Tekin Nacaroglu 1 , * , Canan Sule Unsal Karkiner 1 , Ilker Gunay 1 and Demet Can 1
Authors Information
1 Department of Pediatric Allergy, Dr. Behcet Uz Children's Hospital, Izmir, Turkey
Article information
  • Iranian Journal of Pediatrics: October 28, 2015, 25 (5); e3313
  • Published Online: October 6, 2015
  • Article Type: Research Article
  • Received: August 4, 2015
  • Accepted: August 16, 2015
  • DOI: 10.5812/ijp.3313

To Cite: Erdem S B, Nacaroglu H T, Unsal Karkiner C S, Gunay I, Can D. et al. Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children, Iran J Pediatr. 2015 ; 25(5):e3313. doi: 10.5812/ijp.3313.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Kocyigit A, Gulcan Oksuz B, Yarar F, Uzun F, Igde M, Islek I. Hallucination development with montelukast in a child with asthma: case presentation. Iran J Allergy Asthma Immunol. 2013; 12(4): 397-9[PubMed]
  • 2. Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol. 2009; 44(6): 568-79[DOI][PubMed]
  • 3. Calapai G, Casciaro M, Miroddi M, Calapai F, Navarra M, Gangemi S. Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the Literature Pharmacology. 2014; 94(1-2): 60-70[DOI][PubMed]
  • 4. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA) 2014 (revised),
  • 5. ERS task force. . Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008; 32(4): 1096-1110
  • 6. Drazen JM. Leukotriens, Asthma and Rinitis. 1995; : 838-50
  • 7. O’Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest. 1997; 111: 27-34[PubMed]
  • 8. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis Clin Exp Allergy. 2006; 36(6): 689-703
  • 9. Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, et al. Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study. Ann Allergy Asthma Immunol. 2007; 99(2): 178-84[DOI][PubMed]
  • 10. Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S. Imrovements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest. 2006; 130(6): 1726-1732
  • 11. Mandeep W, Rakesh L, Kabra SK. Montelukast in Pediatric Asthma Management. Indian J Pediatr. 2006; 73(4): 275-82
  • 12. Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RF, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med. 2011; 364(18): 1695-707[DOI][PubMed]
  • 13. Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, et al. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. Eur Respir J. 2003; 21(1): 123-8[PubMed]
  • 14. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet. 2001; 357(9273): 2007-11[DOI][PubMed]
  • 15. Wahn U, Dass SB. Rewiev of recentresults of montelukastuse as a monotherapy in children with mild asthma. Clin Ther. 2008; 30: 1026-35[DOI][PubMed]
  • 16. Montella S, Maglione M, De Stefano S, Manna A, Di Giorgio A, Santamaria F. Update on leukotriene receptor antagonists in preschool children wheezing disorders. Ital J Pediatr. 2012; 38: 29[DOI][PubMed]
  • 17. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005; 171(4): 315-22[DOI][PubMed]
  • 18. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006; 27(3): 495-503[DOI][PubMed]
  • 19. Silva NL, Damayanthi H, Rajapakse AC, Rodrigo C, Rajapakse S. Leukotriene receptor antagonists for chronic urticaria: a systematic review. Allergy Asthma Clin Immunol 2014; 10(1): 24-24
  • 20. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children Cochrane Database Syst Rev. 2012; 16: 5.CD002314
  • 21. Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002; 32(7): 1020-8[PubMed]
  • 22. Wechsler ME, Pauwels R, Drazen JM. Leucotriene modifiers and Churg-Strauss syndrome: advers effect or response to corticosteroid with drawal? Drug Saf. 1999; 21(4): 241-251[PubMed]
  • 23. Xie JX, Wei JF, Meng L.. Montelukast sodiuminduced hematuria: a case report and literature review of 19 cases in mainland China Int J Clin Pharmacol Ther 2013; 51(12): 958-962
  • 24. Cuchacovich R, Justiniano M, Espinoza LR. Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA). Clin Rheumatol. 2007; 26(10): 1769-71[DOI][PubMed]
  • 25. Palodhi S, Ray Chaudhuri P, Biswas A, Bera T. Montelukast induced hypertriglyceridemia Indian Med Gaz 2012; 146: 334-336
  • 26. Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK. A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis J Young Pharm 2013; 5(2): 64-66
  • 27. Ding Q, Fang SH, Zhou Y, Zhang LH, Zhang WP, Chen Z, et al. Cysteinyl leukotriene receptor 1 partially mediates brain cryoinjury in mice. Acta Pharmacol Sin 2007; 28(7): 945-952
  • 28. Philip G, Hustad CM, Malice MP, Noonan G, Ezekowitz A, Reiss TF, et al. Analysis of behavior-related adverse experiences in clinical trials of montelukast. J Allergy Clin Immunol. 2009; 124(4): 699-706[DOI][PubMed]
  • 29. Zileuton, a leukotriene synthesis inhibitor in the management of chronic asthma: clinical pharmacokinetics and safety. Clin Rev Allergy Immunol. 1999; 17(1-2): 213-221
  • 30. Wallerstedt SM, Brunlof G, Sundstrom A, Eriksson AL. Montelukast and psychiatric disorders in children. Pharmacoepidemiol Drug Saf. 2009; 18(9): 858-64[DOI][PubMed]
  • 31. Zhou EH, Kaplan S, Mosholder A, Moeny D, Ding Y, Wu Y, et al. Antidepressant medication dispensing among montelukast initiators. J Asthma. 2013; 50(9): 990-5[DOI][PubMed]
  • 32. Celmeli F, Celmeli G, Surer Adanır A, Türkkahraman D.. Suicide Behaviour After Montelukast Usage: A Case Report Turkish Journal of Pediatric Disease. 2014; 4(8): 212-214
  • 33. Bygdell M, Brunlöf G, Wallerstedt SM, Kindblom JM. Psychiatric advers drug reactions reported during a 10-year period in the Swedish pediatric population Pharmaco epidemiol Drug Saf. 2012; 21(1): 79-86
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments